<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=IARC_group_2B</id>
	<title>IARC group 2B - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=IARC_group_2B"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=IARC_group_2B&amp;action=history"/>
	<updated>2026-04-24T04:00:01Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=IARC_group_2B&amp;diff=6509379&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=IARC_group_2B&amp;diff=6509379&amp;oldid=prev"/>
		<updated>2025-03-17T14:23:20Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:23, 17 March 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l39&quot;&gt;Line 39:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 39:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Toxicology]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Toxicology]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{No image}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{No image}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;__NOINDEX__&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
	<entry>
		<id>https://wikimd.com/index.php?title=IARC_group_2B&amp;diff=6268912&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=IARC_group_2B&amp;diff=6268912&amp;oldid=prev"/>
		<updated>2025-02-11T01:39:33Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 01:39, 11 February 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l38&quot;&gt;Line 38:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 38:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Oncology]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Oncology]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Toxicology]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Toxicology]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{No image}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
	<entry>
		<id>https://wikimd.com/index.php?title=IARC_group_2B&amp;diff=6028988&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=IARC_group_2B&amp;diff=6028988&amp;oldid=prev"/>
		<updated>2024-12-07T21:59:34Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;IARC Group 2B&lt;br /&gt;
&lt;br /&gt;
The International Agency for Research on Cancer (IARC) classifies agents, mixtures, and exposures into different groups based on their carcinogenic risk to humans. &amp;#039;&amp;#039;&amp;#039;IARC Group 2B&amp;#039;&amp;#039;&amp;#039; is a classification used to denote agents that are &amp;quot;possibly carcinogenic to humans.&amp;quot; This classification is used when there is limited evidence of carcinogenicity in humans and less than sufficient evidence in experimental animals.&lt;br /&gt;
&lt;br /&gt;
== Criteria for Classification ==&lt;br /&gt;
The classification into Group 2B is based on the following criteria:&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Limited evidence of carcinogenicity in humans&amp;#039;&amp;#039;&amp;#039;: This means that a positive association has been observed between exposure to the agent and cancer, but other explanations for the observations (such as chance, bias, or confounding) could not be ruled out.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Less than sufficient evidence of carcinogenicity in experimental animals&amp;#039;&amp;#039;&amp;#039;: This indicates that the evidence from animal studies is not strong enough to classify the agent as a probable carcinogen (Group 2A).&lt;br /&gt;
&lt;br /&gt;
== Examples of Group 2B Agents ==&lt;br /&gt;
Some examples of agents classified as Group 2B include:&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Radiofrequency electromagnetic fields&amp;#039;&amp;#039;&amp;#039;: These are emitted by wireless communication devices such as mobile phones.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Lead&amp;#039;&amp;#039;&amp;#039;: Exposure to lead and lead compounds has been associated with various health risks, including potential carcinogenic effects.&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Coffee&amp;#039;&amp;#039;&amp;#039;: Previously classified as Group 2B, coffee has been re-evaluated and is no longer considered a possible carcinogen.&lt;br /&gt;
&lt;br /&gt;
== Implications of Group 2B Classification ==&lt;br /&gt;
The classification of an agent as Group 2B does not mean that it is a definite cause of cancer. Instead, it indicates that there is some evidence suggesting a potential risk, and further research is needed to clarify the relationship between the agent and cancer.&lt;br /&gt;
&lt;br /&gt;
== Research and Evaluation Process ==&lt;br /&gt;
The IARC Monographs program is responsible for evaluating the carcinogenic risks of various agents. The evaluation process involves:&lt;br /&gt;
&lt;br /&gt;
1. &amp;#039;&amp;#039;&amp;#039;Review of scientific literature&amp;#039;&amp;#039;&amp;#039;: Comprehensive review of available studies on the agent.&lt;br /&gt;
2. &amp;#039;&amp;#039;&amp;#039;Assessment of evidence&amp;#039;&amp;#039;&amp;#039;: Evaluation of the quality and strength of the evidence.&lt;br /&gt;
3. &amp;#039;&amp;#039;&amp;#039;Expert panel discussions&amp;#039;&amp;#039;&amp;#039;: Involvement of international experts to discuss and reach a consensus on the classification.&lt;br /&gt;
&lt;br /&gt;
== Also see ==&lt;br /&gt;
* [[IARC Group 1]]&lt;br /&gt;
* [[IARC Group 2A]]&lt;br /&gt;
* [[IARC Group 3]]&lt;br /&gt;
* [[Carcinogen]]&lt;br /&gt;
* [[International Agency for Research on Cancer]]&lt;br /&gt;
&lt;br /&gt;
{{IARC}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Carcinogens]]&lt;br /&gt;
[[Category:Oncology]]&lt;br /&gt;
[[Category:Toxicology]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>